Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is 5.24% vs -23.33% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -115.10% vs 152.63% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is 15.02% vs 51.03% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is 1.69% vs 28.26% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
Compare Quarterly Results Of Shanxi C&Y Pharmaceutical Group Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 5.24% vs -23.33% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -9.58% vs 15.68% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -115.10% vs 152.63% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -112.03% vs 216.43% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is 15.02% vs 51.03% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 15.81% vs 438.89% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 1.69% vs 28.26% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 46.34% vs -67.97% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024






